Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,748 | 340 | 98.2% |
| Education | $106.99 | 24 | 1.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $565.84 | 38 | $0 (2024) |
| Novo Nordisk Inc | $547.59 | 44 | $0 (2024) |
| Allergan, Inc. | $498.33 | 66 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $429.13 | 22 | $0 (2024) |
| ITI, Inc. | $410.79 | 15 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $398.14 | 21 | $0 (2021) |
| GlaxoSmithKline, LLC. | $347.64 | 27 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $333.92 | 17 | $0 (2023) |
| Lilly USA, LLC | $318.44 | 19 | $0 (2024) |
| ABBVIE INC. | $294.55 | 16 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $178.87 | 11 | Otsuka America Pharmaceutical, Inc. ($34.91) |
| 2023 | $859.94 | 38 | Corium, LLC ($149.13) |
| 2022 | $676.48 | 31 | ITI, Inc. ($282.21) |
| 2021 | $691.09 | 40 | AbbVie Inc. ($204.95) |
| 2020 | $620.79 | 34 | AstraZeneca Pharmaceuticals LP ($200.68) |
| 2019 | $758.89 | 33 | Janssen Pharmaceuticals, Inc ($167.32) |
| 2018 | $846.49 | 62 | Allergan Inc. ($160.08) |
| 2017 | $1,222 | 115 | Allergan Inc. ($312.05) |
All Payment Transactions
364 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/14/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $15.30 | General |
| Category: Diabetes | ||||||
| 04/30/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $17.99 | General |
| Category: PSYCHIATRY | ||||||
| 04/09/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.55 | General |
| Category: Gastroenterology | ||||||
| 03/18/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $17.75 | General |
| Category: PSYCHIATRY | ||||||
| 02/26/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $16.53 | General |
| Category: Diabetes | ||||||
| 02/08/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.81 | General |
| Category: Respiratory | ||||||
| 02/05/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $13.72 | General |
| Category: RESPIRATORY | ||||||
| 02/01/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $16.90 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 01/11/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $16.92 | General |
| Category: PSYCHIATRY | ||||||
| 01/09/2024 | Biogen, Inc. | SKYCLARYS (Drug) | Food and Beverage | In-kind items and services | $19.41 | General |
| Category: Neurology | ||||||
| 01/08/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.99 | General |
| Category: Diabetes | ||||||
| 12/14/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $18.62 | General |
| Category: Respiratory | ||||||
| 12/11/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $17.75 | General |
| Category: Diabetes | ||||||
| 12/06/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA, SHINGRIX | Food and Beverage | In-kind items and services | $18.92 | General |
| Category: RESPIRATORY | ||||||
| 11/13/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $14.28 | General |
| Category: Oncology | ||||||
| 11/06/2023 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $19.87 | General |
| Category: PSYCHIATRY | ||||||
| 10/17/2023 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $70.56 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 10/16/2023 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $18.51 | General |
| Category: PSYCHIATRY | ||||||
| 10/03/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $5.10 | General |
| Category: PSYCHIATRY | ||||||
| 09/26/2023 | Biogen, Inc. | Skyclarys (Drug) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: Neurology | ||||||
| 09/08/2023 | Corium, LLC | Adlarity (Drug) | Food and Beverage | In-kind items and services | $24.82 | General |
| Category: Treatment of dementia of the Alzheimers type | ||||||
| 09/06/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $5.14 | General |
| Category: PSYCHIATRY | ||||||
| 09/01/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA, SHINGRIX | Food and Beverage | In-kind items and services | $14.05 | General |
| Category: RESPIRATORY | ||||||
| 08/30/2023 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $17.71 | General |
| Category: PSYCHIATRY | ||||||
| 08/28/2023 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $16.13 | General |
| Category: Bone Health | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 570 | 946 | $125,035 | $62,318 |
| 2022 | 18 | 624 | 1,058 | $141,072 | $68,577 |
| 2021 | 20 | 637 | 1,072 | $130,067 | $66,479 |
| 2020 | 24 | 904 | 1,505 | $176,033 | $82,241 |
All Medicare Procedures & Services
81 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 132 | 238 | $45,220 | $18,417 | 40.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 93 | 93 | $16,760 | $11,393 | 68.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 21 | 87 | $8,265 | $5,301 | 64.1% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 15 | 76 | $11,020 | $5,274 | 47.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 28 | 40 | $8,800 | $4,801 | 54.6% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 45 | 59 | $7,375 | $3,651 | 49.5% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 21 | 63 | $3,150 | $2,419 | 76.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 39 | 49 | $6,860 | $2,410 | 35.1% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 20 | 25 | $4,000 | $2,401 | 60.0% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 27 | 32 | $3,840 | $2,054 | 53.5% |
| 20550 | Injection into tendon or ligament | Office | 2023 | 23 | 38 | $3,040 | $1,288 | 42.4% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Office | 2023 | 14 | 26 | $2,860 | $1,266 | 44.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 26 | 31 | $2,790 | $1,022 | 36.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 11 | 11 | $275.00 | $269.50 | 98.0% |
| 90688 | Influenza vaccine, quadrivalent, 0.5 ml dosage | Office | 2023 | 11 | 11 | $385.00 | $225.06 | 58.5% |
| 81002 | Urinalysis, manual test | Office | 2023 | 21 | 30 | $210.00 | $102.30 | 48.7% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 23 | 37 | $185.00 | $24.71 | 13.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 133 | 238 | $44,880 | $18,066 | 40.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 107 | 107 | $19,260 | $13,413 | 69.6% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 27 | 146 | $13,870 | $7,975 | 57.5% |
| 99309 | Follow-up nursing facility visit per day, typically 25 minutes | Office | 2022 | 23 | 96 | $13,920 | $5,170 | 37.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 25 | 34 | $7,480 | $4,529 | 60.6% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 50 | 71 | $8,875 | $3,911 | 44.1% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 29 | 35 | $5,600 | $3,350 | 59.8% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 27 | 85 | $4,250 | $2,533 | 59.6% |
About Dr. Robert Hafford, MD
Dr. Robert Hafford, MD is a Family Medicine healthcare provider based in Essexville, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/30/2005. The National Provider Identifier (NPI) number assigned to this provider is 1720075229.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Hafford, MD has received a total of $5,855 in payments from pharmaceutical and medical device companies, with $178.87 received in 2024. These payments were reported across 364 transactions from 34 companies. The most common payment nature is "Food and Beverage" ($5,748).
As a Medicare-enrolled provider, Hafford has provided services to 2,735 Medicare beneficiaries, totaling 4,581 services with total Medicare billing of $279,615. Data is available for 4 years (2020–2023), covering 81 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Essexville, MI
- Active Since 09/30/2005
- Last Updated 11/20/2009
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1720075229
Products in Payments
- ELIQUIS (Drug) $483.91
- CAPLYTA (Drug) $410.79
- VRAYLAR (Drug) $371.88
- XARELTO (Drug) $357.59
- REXULTI (Drug) $324.23
- ENTRESTO (Drug) $298.80
- CHANTIX (Drug) $214.41
- MYRBETRIQ (Drug) $158.59
- SYMBICORT (Drug) $153.08
- Victoza (Drug) $142.34
- BREZTRI AEROSPHERE (Drug) $141.02
- NAMZARIC (Drug) $123.09
- Vascepa (Drug) $121.69
- WATCHMAN Access System (Device) $109.67
- BREZTRI (Drug) $107.37
- Rybelsus (Drug) $100.57
- Saxenda (Drug) $98.78
- TRULICITY (Drug) $98.15
- TRELEGY ELLIPTA (Drug) $93.09
- ADVAIR (Drug) $90.39
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Essexville
Dr. William Morrone, Do, DO
Family Medicine — Payments: $17,147
Erin Campau
Family Medicine — Payments: $8,641
Michelle Doran, Do, DO
Family Medicine — Payments: $6,448
Rupendra Ghatak
Family Medicine — Payments: $2,380
Melissa Kohner, Do, DO
Family Medicine — Payments: $2,108
Peter Huynh
Family Medicine — Payments: $1,407